Drug Development and Industrial Pharmacy 2011-01-01

Monoolein cubic phase containing acidic proteinoid: pH-dependent release.

Taek Kwan Kwon, Jin-Chul Kim

Index: Drug Dev. Ind. Pharm. 37(1) , 56-61, (2011)

Full Text: HTML

Abstract

Monoolein (MO) cubic phase containing acidic proteinoid was prepared for a pH-dependent release.The acidic proteinoid was prepared by a thermal-condensation reaction of Asp and Leu (9.85/0.15 in molar ratio). To prepare MO cubic phase, molten MO was hydrated with the proteinoid solution in distilled water. For pH-dependent release experiment, amaranth was included as an anionic dye, and either auramine O or methylene blue was contained as a cationic dye.The release of amaranth from the cubic phase was promoted under neutral and alkali conditions, possibly because of electrostatic repulsions between the anionic dye and the ionized carboxylic group of the acidic proteinoid. On the contrary, the releases of auramine O and methylene blue were suppressed under neutral and alkali conditions, probably because of electrostatic interactions between the cationic dyes and the ionized carboxylic group.The acidic proteinoid is believed to control the releases in response to change in pH.

Related Compounds

  • Auramine O
  • Amaranth

Related Articles:

Functional and genetic characterization of the tap efflux pump in Mycobacterium bovis BCG.

2012-04-01

[Antimicrob. Agents Chemother. 56(4) , 2074-83, (2012)]

Confocal laser scanning microscopy elucidation of the micromorphology of the leaf cuticle and analysis of its chemical composition.

2015-11-01

[Protoplasma 252 , 1475-86, (2015)]

Efficacy of real-time polymerase chain reaction for rapid diagnosis of endobronchial tuberculosis

2004-01-01

[Int. J. Infect. Dis. 27 , 13-7, (2014)]

Analysis and testing of biological stains--the Biological Stain Commission Procedures.

2002-01-01

[Biotech. Histochem. 77(5&6) , 237-275, (2002)]

A prospective evaluation of selection criteria for the use of Nucleic Acid Amplification Techniques to test for the presence of Mycobacterium tuberculosis in respiratory tract samples.

2009-01-01

[Clin. Lab. 55(11-12) , 441-6, (2009)]

More Articles...